Format

Send to:

Choose Destination
See comment in PubMed Commons below
Stem Cell Res Ther. 2010 Mar 15;1(1):2. doi: 10.1186/scrt2.

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

Author information

  • 1Inserm, U844, Montpellier F-34091, France. soufiane.ghannam@inserm.fr

Abstract

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitor cells that are isolated from many adult tissues, in particular from the bone marrow and adipose tissue. Along with their capacity for differentiating into cells of mesodermal lineage, such as adipocytes, osteoblasts and chondrocytes, these cells have also generated great interest for their ability to display immunomodulatory capacities. Indeed, a major breakthrough came with the finding that they are able to induce peripheral tolerance, suggesting they may be used as therapeutic tools in immune-mediated disorders. The present review aims at discussing the current knowledge on the targets and mechanisms of MSC-mediated immunosuppression as well as the potential use of MSCs as modulators of immune responses in a variety of diseases related to alloreactive immunity or autoimmunity.

PMID:
20504283
[PubMed - indexed for MEDLINE]
PMCID:
PMC2873698
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk